3-133756878-C-T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001063.4(TF):​c.739C>T​(p.Leu247Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.109 in 1,614,108 control chromosomes in the GnomAD database, including 10,732 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. L247L) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.11 ( 1030 hom., cov: 32)
Exomes 𝑓: 0.11 ( 9702 hom. )

Consequence

TF
NM_001063.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.268

Publications

65 publications found
Variant links:
Genes affected
TF (HGNC:11740): (transferrin) This gene encodes a glycoprotein with an approximate molecular weight of 76.5 kDa. It is thought to have been created as a result of an ancient gene duplication event that led to generation of homologous C and N-terminal domains each of which binds one ion of ferric iron. The function of this protein is to transport iron from the intestine, reticuloendothelial system, and liver parenchymal cells to all proliferating cells in the body. This protein may also have a physiologic role as granulocyte/pollen-binding protein (GPBP) involved in the removal of certain organic matter and allergens from serum. [provided by RefSeq, Sep 2009]
TF Gene-Disease associations (from GenCC):
  • atransferrinemia
    Inheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics, Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.63).
BP6
Variant 3-133756878-C-T is Benign according to our data. Variant chr3-133756878-C-T is described in ClinVar as Benign. ClinVar VariationId is 343439.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.268 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.235 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TFNM_001063.4 linkc.739C>T p.Leu247Leu synonymous_variant Exon 7 of 17 ENST00000402696.9 NP_001054.2 P02787Q06AH7A0PJA6
TFNM_001354703.2 linkc.607C>T p.Leu203Leu synonymous_variant Exon 13 of 23 NP_001341632.2
TFNM_001354704.2 linkc.358C>T p.Leu120Leu synonymous_variant Exon 6 of 16 NP_001341633.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TFENST00000402696.9 linkc.739C>T p.Leu247Leu synonymous_variant Exon 7 of 17 1 NM_001063.4 ENSP00000385834.3 P02787
TFENST00000482271.5 linkc.358C>T p.Leu120Leu synonymous_variant Exon 6 of 6 4 ENSP00000419338.1 C9JVG0
TFENST00000485977.1 linkn.158-54C>T intron_variant Intron 2 of 4 3 ENSP00000418716.1 F8WC57

Frequencies

GnomAD3 genomes
AF:
0.108
AC:
16433
AN:
152114
Hom.:
1028
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0632
Gnomad AMI
AF:
0.0833
Gnomad AMR
AF:
0.133
Gnomad ASJ
AF:
0.118
Gnomad EAS
AF:
0.246
Gnomad SAS
AF:
0.160
Gnomad FIN
AF:
0.174
Gnomad MID
AF:
0.165
Gnomad NFE
AF:
0.105
Gnomad OTH
AF:
0.110
GnomAD2 exomes
AF:
0.131
AC:
32867
AN:
251486
AF XY:
0.131
show subpopulations
Gnomad AFR exome
AF:
0.0617
Gnomad AMR exome
AF:
0.132
Gnomad ASJ exome
AF:
0.123
Gnomad EAS exome
AF:
0.267
Gnomad FIN exome
AF:
0.167
Gnomad NFE exome
AF:
0.107
Gnomad OTH exome
AF:
0.136
GnomAD4 exome
AF:
0.109
AC:
159010
AN:
1461874
Hom.:
9702
Cov.:
33
AF XY:
0.110
AC XY:
80024
AN XY:
727238
show subpopulations
African (AFR)
AF:
0.0596
AC:
1997
AN:
33480
American (AMR)
AF:
0.133
AC:
5954
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.122
AC:
3193
AN:
26136
East Asian (EAS)
AF:
0.225
AC:
8935
AN:
39700
South Asian (SAS)
AF:
0.147
AC:
12688
AN:
86258
European-Finnish (FIN)
AF:
0.166
AC:
8874
AN:
53420
Middle Eastern (MID)
AF:
0.138
AC:
797
AN:
5768
European-Non Finnish (NFE)
AF:
0.0983
AC:
109341
AN:
1111994
Other (OTH)
AF:
0.120
AC:
7231
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
9215
18429
27644
36858
46073
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4010
8020
12030
16040
20050
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.108
AC:
16433
AN:
152234
Hom.:
1030
Cov.:
32
AF XY:
0.113
AC XY:
8432
AN XY:
74414
show subpopulations
African (AFR)
AF:
0.0631
AC:
2623
AN:
41558
American (AMR)
AF:
0.133
AC:
2028
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.118
AC:
410
AN:
3468
East Asian (EAS)
AF:
0.246
AC:
1273
AN:
5174
South Asian (SAS)
AF:
0.159
AC:
769
AN:
4824
European-Finnish (FIN)
AF:
0.174
AC:
1845
AN:
10578
Middle Eastern (MID)
AF:
0.160
AC:
47
AN:
294
European-Non Finnish (NFE)
AF:
0.105
AC:
7125
AN:
68014
Other (OTH)
AF:
0.112
AC:
237
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
728
1457
2185
2914
3642
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
194
388
582
776
970
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.108
Hom.:
4040
Bravo
AF:
0.104
Asia WGS
AF:
0.200
AC:
692
AN:
3478
EpiCase
AF:
0.104
EpiControl
AF:
0.107

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Atransferrinemia Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

TF-related disorder Benign:1
Oct 21, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.63
CADD
Benign
8.5
DANN
Benign
0.83
PhyloP100
-0.27
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1799852; hg19: chr3-133475722; COSMIC: COSV53917870; COSMIC: COSV53917870; API